SIGNAL
DEAD

Serial Number

97090822

Owner

FUSE Oncology, Inc.

Attorney

Kimberly Bullock Gatling

Filing Date

Oct 25, 2021

Add to watchlist:

No watchlists yet
View on USPTO

SIGNAL Trademark

Serial Number: 97090822

SIGNAL is a trademark filed by FUSE Oncology, Inc. on October 25, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

FUSE Oncology, Inc. (5 trademarks)

Boone, NC 28607

Entity Type: 03

Trademark Details

Filing Date

October 25, 2021

Registration Date

Not Registered

Goods & Services

Downloadable computer software for integrating electronic health records (EHR) for oncology with broader electronic health records (EHR) systems and managing oncology patient workflows from physician intent to billing, excluding downloadable computer software for use as a clinical trials research platform

Software as a service (SAAS) services featuring software for integrating electronic health records (EHR) for oncology with broader electronic health records (EHR) systems and managing oncology patient workflows from physician intent to billing, excluding software as a service (SAAS) services for use as a clinical trials research platform

Filing History

ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Jul 13, 2023 MAB3
ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Jul 13, 2023 MAB3
ABANDONMENT - AFTER EX PARTE APPEAL
Jul 12, 2023 ABN3
EXPARTE APPEAL TERMINATED
Jul 12, 2023 EXPT
EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
Jul 12, 2023 EXFB
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Apr 27, 2023 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Apr 27, 2023 GECD
ACTION CONTINUING FINAL - COMPLETED
Apr 27, 2023 CNCF
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 3, 2023 ERFR
EX PARTE APPEAL-INSTITUTED
Apr 3, 2023 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Apr 3, 2023 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Apr 3, 2023 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 13, 2023 GNFN
FINAL REFUSAL E-MAILED
Jan 13, 2023 GNFR
FINAL REFUSAL WRITTEN
Jan 13, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 23, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 22, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 22, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 28, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jun 28, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jun 28, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 20, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 8, 2021 NWOS
NEW APPLICATION ENTERED
Oct 28, 2021 NWAP